arabinofuranosyluracil has been researched along with Leukemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Fu, G; Hu, S; Liao, C; Tang, Z | 1 |
| Bjornsson, T; Capizzi, RL; Cheng, E; Cheng, YC; Sahasrabudhe, D; Tan, RS; Yang, JL | 1 |
| Akiyama, Y; Ando, S; Johno, I; Kagawa, D; Nakamura, T; Sasada, M; Uchino, H; Ueda, T | 1 |
| Breithaupt, H; Eckhardt, T; Löffler, H; Pralle, H; Schick, J; von Hattingberg, M | 1 |
| Drenthe-Schonk, A; Haanen, C; Linssen, P; Wessels, H | 1 |
| Breithaupt, H; Schick, J | 1 |
| Avramis, VI; Periclou, AP | 1 |
| Arning, M; Burk, M; Fartash, K; Heyll, A; Schneider, W; Volmer, M | 1 |
| Chuang, LF; Chuang, RY | 1 |
| Lasorella, A; Riccardi, A; Riccardi, R; Servidei, T | 1 |
| Domae, N; Kagawa, D; Nakamura, T; Sasada, M; Sugiyama, M; Uchida, M; Uchino, H; Ueda, T; Ueda, Y | 1 |
| Capizzi, RL; Wang, LM; White, JC; Woodward, CN | 1 |
| Preisler, HD; Riva, C; Rustum, YM | 1 |
| Capizzi, RL; Cheng, E; Cheng, YC; Kute, T; Rathmell, JP; White, JC; Yang, JL | 1 |
1 review(s) available for arabinofuranosyluracil and Leukemia
| Article | Year |
|---|---|
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
1 trial(s) available for arabinofuranosyluracil and Leukemia
| Article | Year |
|---|---|
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
13 other study(ies) available for arabinofuranosyluracil and Leukemia
| Article | Year |
|---|---|
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of 1-β-d-arabinofuranosyluracil in human plasma and application to therapeutic drug monitoring in patient with leukemia.
Topics: Arabinofuranosyluracil; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Leukemia; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2013 |
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.
Topics: Acute Disease; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Deaminase; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Leukemia; Models, Biological; Nucleoside Deaminases; Radioimmunoassay; Time Factors; Uridine | 1983 |
Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
Topics: Acute Disease; Adult; Antineoplastic Agents; Arabinofuranosyluracil; Bone Marrow; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytarabine; Erythrocytes; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infusions, Parenteral; Kinetics; Leukemia; Middle Aged; Time Factors | 1983 |
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C).
Topics: Adult; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Kinetics; Leukemia; Male; Metabolic Clearance Rate; Middle Aged; Teratoma; Time Factors | 1982 |
Determination of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil in human plasma by high-performance liquid chromatography.
Topics: Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Humans; Leukemia; Uridine | 1981 |
Determination of cytarabine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatography.
Topics: Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Humans; Leukemia; Time Factors; Uridine | 1981 |
NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
Topics: Adolescent; Adult; Arabinofuranosyluracil; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytarabine; Half-Life; Humans; Infant; Infusions, Intravenous; Leukemia; Metabolic Clearance Rate; Models, Biological | 1996 |
Pharmacokinetics of high-dose cytarabine and its deamination product--a reappraisal.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Cytarabine; Deamination; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes | 1997 |
Inhibition of RNA polymerase as a possible anti-leukaemic action of cytosine arabinoside.
Topics: Arabinofuranosyluracil; Cell-Free System; Cells, Cultured; Cytarabine; DNA-Directed RNA Polymerases; Kinetics; Leukemia; Structure-Activity Relationship | 1976 |
High-performance liquid chromatographic assay for cytosine arabinoside and uracil arabinoside in cerebrospinal fluid and plasma.
Topics: Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Humans; Leukemia; Spectrophotometry, Ultraviolet; Uridine | 1989 |
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Polycythemia Vera | 1989 |
Determination of 3H-labelled cytosine arabinoside and eight metabolites in cell extracts by high-performance liquid chromatography and scintillation spectrometry.
Topics: Arabinofuranosyluracil; Cell Line; Chromatography, High Pressure Liquid; Cytarabine; Humans; Hydrogen-Ion Concentration; Leukemia; Scintillation Counting; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 1989 |
Pharmacokinetic parameters of 1-beta-D-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute nonlymphocytic leukemia treated with conventional and high-dose ara-C.
Topics: Acute Disease; Animals; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Humans; Leukemia; Leukemia L1210; Metabolic Clearance Rate; Mice; Uridine Kinase | 1987 |